Commensalism or symbiosis: The potential use of rituximab in steroid-refractory Evans syndrome in a patient with ulcerative colitis

Detalles Bibliográficos
Autores principales: Ahmed, Eyad, Hoe Chan, Kok, Veeraballi, Sindhusha, Dacosta, Theodore, Shaaban, Hamid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish League Against Rheumatism 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326375/
https://www.ncbi.nlm.nih.gov/pubmed/35949878
http://dx.doi.org/10.46497/ArchRheumatol.2022.8898
_version_ 1784757270775595008
author Ahmed, Eyad
Hoe Chan, Kok
Veeraballi, Sindhusha
Dacosta, Theodore
Shaaban, Hamid
author_facet Ahmed, Eyad
Hoe Chan, Kok
Veeraballi, Sindhusha
Dacosta, Theodore
Shaaban, Hamid
author_sort Ahmed, Eyad
collection PubMed
description
format Online
Article
Text
id pubmed-9326375
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Turkish League Against Rheumatism
record_format MEDLINE/PubMed
spelling pubmed-93263752022-08-09 Commensalism or symbiosis: The potential use of rituximab in steroid-refractory Evans syndrome in a patient with ulcerative colitis Ahmed, Eyad Hoe Chan, Kok Veeraballi, Sindhusha Dacosta, Theodore Shaaban, Hamid Arch Rheumatol Letter Turkish League Against Rheumatism 2021-10-18 /pmc/articles/PMC9326375/ /pubmed/35949878 http://dx.doi.org/10.46497/ArchRheumatol.2022.8898 Text en Copyright © 2022, Turkish League Against Rheumatism https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Letter
Ahmed, Eyad
Hoe Chan, Kok
Veeraballi, Sindhusha
Dacosta, Theodore
Shaaban, Hamid
Commensalism or symbiosis: The potential use of rituximab in steroid-refractory Evans syndrome in a patient with ulcerative colitis
title Commensalism or symbiosis: The potential use of rituximab in steroid-refractory Evans syndrome in a patient with ulcerative colitis
title_full Commensalism or symbiosis: The potential use of rituximab in steroid-refractory Evans syndrome in a patient with ulcerative colitis
title_fullStr Commensalism or symbiosis: The potential use of rituximab in steroid-refractory Evans syndrome in a patient with ulcerative colitis
title_full_unstemmed Commensalism or symbiosis: The potential use of rituximab in steroid-refractory Evans syndrome in a patient with ulcerative colitis
title_short Commensalism or symbiosis: The potential use of rituximab in steroid-refractory Evans syndrome in a patient with ulcerative colitis
title_sort commensalism or symbiosis: the potential use of rituximab in steroid-refractory evans syndrome in a patient with ulcerative colitis
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326375/
https://www.ncbi.nlm.nih.gov/pubmed/35949878
http://dx.doi.org/10.46497/ArchRheumatol.2022.8898
work_keys_str_mv AT ahmedeyad commensalismorsymbiosisthepotentialuseofrituximabinsteroidrefractoryevanssyndromeinapatientwithulcerativecolitis
AT hoechankok commensalismorsymbiosisthepotentialuseofrituximabinsteroidrefractoryevanssyndromeinapatientwithulcerativecolitis
AT veeraballisindhusha commensalismorsymbiosisthepotentialuseofrituximabinsteroidrefractoryevanssyndromeinapatientwithulcerativecolitis
AT dacostatheodore commensalismorsymbiosisthepotentialuseofrituximabinsteroidrefractoryevanssyndromeinapatientwithulcerativecolitis
AT shaabanhamid commensalismorsymbiosisthepotentialuseofrituximabinsteroidrefractoryevanssyndromeinapatientwithulcerativecolitis

Ejemplares similares